Daniel Len Edmonston, MD

Assistant Professor of Medicine
Member in the Duke Clinical Research Institute
Email address daniel.edmonston@duke.edu

My primary research focus lies at the intersection of kidney and cardiovascular disease including pulmonary hypertension, heart failure, and atherosclerotic disease in patients with chronic kidney disease. 

Education and Training

  • Fellowship, Nephrology, Duke University, 2016 - 2019
  • Residency, Medicine, New York Presbyterian Hospital, 2013 - 2016
  • M.D., Mercer University, School of Medicine, 2013

Publications

Hsu, Caroline M., Shruti Gupta, Hocine Tighiouart, Nitender Goyal, Anthony J. Faugno, Asma Tariq, Ritesh Raichoudhury, et al. “Kidney Recovery and Death in Critically Ill Patients With COVID-19-Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study.” Am J Kidney Dis 79, no. 3 (March 2022): 404-416.e1. https://doi.org/10.1053/j.ajkd.2021.11.004.

PMID
34871701
Full Text

Sata, Suchita Shah, Susan E. Spratt, Daniel L. Edmonston, and Neha Pagidipati. “Clinical progress note: Indications for and management of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in hospitalized patients.” J Hosp Med, February 28, 2022. https://doi.org/10.1002/jhm.12798.

PMID
35535917
Full Text

Edmonston, Daniel L., Roland Matsouaka, Svati H. Shah, Sudarshan Rajagopal, and Myles Wolf. “Noninvasive Risk Score to Screen for Pulmonary Hypertension With Elevated Pulmonary Vascular Resistance in Diseases of Chronic Volume Overload.” Am J Cardiol 159 (November 15, 2021): 113–20. https://doi.org/10.1016/j.amjcard.2021.08.016.

PMID
34497006
Full Text

Friedman, Allon N., John Guirguis, Rajat Kapoor, Shruti Gupta, David E. Leaf, Lava R. Timsina, and Lava R. STOP-COVID Investigators. “Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US.” Obesity (Silver Spring) 29, no. 10 (October 2021): 1719–30. https://doi.org/10.1002/oby.23245.

PMID
34109768
Full Text

Jezmir, Julia L., Maheetha Bharadwaj, Alexander Chaitoff, Bradford Diephuis, Conor P. Crowley, Sandeep P. Kishore, Eric Goralnick, et al. “Performance of crisis standards of care guidelines in a cohort of critically ill COVID-19 patients in the United States.” Cell Rep Med 2, no. 9 (September 21, 2021): 100376. https://doi.org/10.1016/j.xcrm.2021.100376.

PMID
34337554
Full Text

Vasquez, Charles R., Shruti Gupta, Todd A. Miano, Meaghan Roche, Jesse Hsu, Wei Yang, Daniel N. Holena, et al. “Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19.” Chest 160, no. 3 (September 2021): 929–43. https://doi.org/10.1016/j.chest.2021.04.062.

PMID
33964301
Full Text

Edmonston, Daniel L., Tamara Isakova, Laura M. Dember, Steven Brunelli, Amy Young, Rebecca Brosch, Srinivasan Beddhu, Hrishikesh Chakraborty, and Myles Wolf. “Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis.” Am J Kidney Dis 77, no. 6 (June 2021): 920-930.e1. https://doi.org/10.1053/j.ajkd.2020.10.008.

PMID
33279558
Full Text

Cohen, Jordana B., Thomas C. Hanff, Preethi William, Nancy Sweitzer, Nelson R. Rosado-Santander, Carola Medina, Juan E. Rodriguez-Mori, et al. “Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.” Lancet Respir Med 9, no. 3 (March 2021): 275–84. https://doi.org/10.1016/S2213-2600(20)30558-0.

PMID
33422263
Full Text

Flythe, Jennifer E., Magdalene M. Assimon, Matthew J. Tugman, Emily H. Chang, Shruti Gupta, Jatan Shah, Marie Anne Sosa, et al. “Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States.” Am J Kidney Dis 77, no. 2 (February 2021): 190-203.e1. https://doi.org/10.1053/j.ajkd.2020.09.003.

PMID
32961244
Full Text

Pages